Quantum Computing Report

QC Ware and IonQ Achieve Chemical Accuracy in Hybrid Quantum Chemistry Workflow for Drug Discovery

Quantum software developer QC Ware and trapped-ion hardware vendor IonQ (NYSE: IONQ) have demonstrated a hybrid quantum-classical chemistry workflow combining QC Ware’s Promethium® platform with the IonQ Forte quantum computer. Executed via Amazon Braket and supported by AWS cloud compute credits, the joint test calculated electrostatic interaction energy within 0.5 kcal/mol (~4%) of classical benchmarks—clearing the 1 kcal/mol threshold required for true chemical accuracy in enzyme active-site modeling.

[ QC Ware Promethium & IonQ Forte Benchmark Overview ]
Biological Target & System ScaleQuantum Active Space & Hardware MappingComputational Performance & Accuracy
• Cytochrome P450nor Heme Active Site• 4-Orbital Strongly Correlated Active Space• Electrostatic Interaction Energy Within 0.5 kcal/mol (~4%)
• Complex 115-Atom Active Site Model• Mapped onto 8 Qubits (IonQ Forte)• Sub-1 kcal/mol Chemical Accuracy Threshold Cleared
• Over 1,000 Molecular Orbitals Preprocessed• Single-Basis Measurement via All-to-All Connectivity• Double the Accuracy of Standard Classical Mean-Field Methods

Targeting Heme Active Sites in Drug Metabolism

The demonstration modeled the iron-containing heme active site of cytochrome P450nor, a nitric oxide reductase belonging to the cytochrome P450 superfamily—the primary enzyme family responsible for human drug metabolism. Accurately modeling electrostatic binding energies at transition-metal active sites allows biopharma discovery teams to rank candidate molecules more reliably and flag metabolic or toxicity risks earlier in R&D pipelines:

Review the full press release on PR Newswire here.

September 1, 2026

Exit mobile version